Propel Bio Partners

Propel Bio Partners is a private equity investment firm established in March 2022 and headquartered in Los Angeles, California. Founded by Dr. Leen Kawas and Richard Kayne, the firm focuses on investing in high-potential companies within the biosciences sector, particularly those with disruptive technologies that are ready for clinical trials or regulatory approval. Propel Bio Partners aims to provide both capital and strategic guidance to its portfolio companies. Dr. Kawas, who has extensive experience in drug discovery and clinical trials from her previous role as Co-Founder and CEO of a pharmaceutical company, leads the firm alongside Richard Kayne, a veteran in private equity and venture capital. They are joined by Dr. Dasom Yoo, a Senior Advisor with expertise in regenerative medicine. The firm’s advisory board consists of leaders from prominent biosciences companies and government agencies, ensuring that their investments benefit from specialized knowledge in research, medicine, and business.